Year-over-year net earnings per share growth for the last 12 months: Telesis Bio, Inc (TBIO)

Graphic logo of Telesis Bio (TBIO)

Telesis Bio, Inc. (TBIO) develops automated platforms for mRNA and DNA synthesis, leveraging demand within the gene therapy sector. The company is expanding its distribution network through laboratory equipment suppliers to avoid significant capital expenditures. However, operating losses and competition are creating pressure. The quarterly EPS growth trajectory on GURU.Markets reflects the business dynamics, where the value of -49.80 serves as a baseline indicator of fundamental stability.

telesisbio.com (TBIO) - Year-over-year earnings per share growth for the last twelve months from 04/28/2023 to 10/05/2024

Analytical breakdowns for Telesis Bio, Inc.

- market value and analyst target forecast:
Price Chart Telesis Bio|TBIO - Analyst Median Target
- company stock exchange capitalization indicators:
Market Valuation Codex DNA|TBIO - Value Adjusted for Debt and Cash
- book capitalization indicators:
Book Value per Share Telesis Bio|TBIO - Company Book Value|Market Capitalization to Book Value Ratio telesisbio.com|TBIO - Company Total Asset Base
- business debt structure and liquidity details:
Debt to Equity Telesis Bio, Inc.|TBIO - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Telesis Bio, Inc.|TBIO - Aggregate Debt Obligations|Debts to Book Capitalization Codex DNA|TBIO - Long-Term Debt Volume|Company Short-Term Debt Telesis Bio|Quick Ratio telesisbio.com
- earnings and valuation multiples indicators:
TBIO - Net Income|Future Profit Telesis Bio, Inc.|TBIO - Business Payback Period|Projected Price to Earnings Codex DNA|TBIO - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple Codex DNA|TBIO - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Telesis Bio|TBIO - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months telesisbio.com|TBIO - Earnings per share growth rate in current year|Earnings growth forecast for next year Telesis Bio, Inc.
- sales volume and revenue information:
TBIO - Company Sales Volume|Company Projected Revenue Telesis Bio|TBIO - Market Cap to Revenue Ratio|Forward P/S Multiple Codex DNA
Summary company analytics:Telesis Bio - TBIO
Manufactured product of telesisbio.com

Investors assess operational resilience through the percentage change in earnings per share, which neutralizes seasonality and reveals the actual profitability trend between reports. By analyzing the quarterly earnings per share dynamics, one can determine how effectively the production and logistics outsourcing of Telesis Bio (TBIO) reduces costs, transforming operational optimization into stable growth of net equity.

Competitors of Telesis Bio, Inc. (TBIO)

Tempus AI Inc (TEM) - Year-over-year earnings per share growth for the last twelve months|QGEN - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months IONS|RGEN: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth RNA|Year-over-year earnings per share growth for the last twelve months CRSP (crisprtx.com)|Quarterly EPS earnings growth WGS (GeneDx)|Year-over-year net earnings per share change for the last twelve months Ultragenyx Pharmaceutical Inc. (RARE)|BEAM - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Sarepta Corp|TWST (Twist Bioscience) - Year-over-year net earnings per share growth for the last 12 months|10xgenomics.com - Year-over-year earnings per one share growth for the last 12 months|NTLA (Intellia Therapeutics, Inc.) - Quarterly EPS earnings growth|Stoke Therapeutics Inc (STOK) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months BioLife Corp (BLFS)|Wave Pharma - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth MAZE (Maze Therapeutics Inc)|SION - Year-over-year net earnings per share growth for the last 12 months|PRME: Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share change for the last twelve months Taysha Gene Therapies Inc TSHA|QURE (uniQure Corp) - Year-over-year net earnings per share growth for the last 12 months|MGTX: Year-over-year earnings per share growth rate for the last twelve months|RGNX (REGENXBIO Inc.) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months SLDB|Quarterly EPS earnings growth OCGN|Year-over-year net earnings per share change for the last twelve months Pacific Biosciences of California, Inc.|Year-over-year earnings per share growth for the last twelve months Benitec BNTC|Design Corp (DSGN) - Earnings per share growth in annualized terms for the last twelve months|Rocket Pharmaceuticals - Quarterly EPS earnings growth|FDMT (4dmoleculartherapeutics.com) - Year-over-year earnings per share growth for the last 12 months|lexeotx.com (LXEO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months KRRO|EDIT (Editas) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Silence Therapeutics Corp|Year-over-year net earnings per share growth for the last 12 months PRQR (ProQR Therapeutics N.V.)|Year-over-year earnings per share growth rate for the last twelve months CDXS|Quarterly EPS earnings growth SGMO (Sangamo Therapeutics, Inc.)|Nautilus Biotechnology, Inc. (NAUT) - Earnings per share growth in annualized terms for the last twelve months|MGX - Year-over-year earnings per share growth for the last twelve months|DTIL: Year-over-year earnings per share growth for the last twelve months|GBIO: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months boundlessbio.com (BOLD)|Year-over-year earnings per share growth for the last twelve months Exicure Inc.|Celsion Corporation (IMNN) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth PHIO|Year-over-year net earnings per share change for the last twelve months mustangbio.com|Year-over-year earnings per share growth for the last twelve months TransCode Therapeutics, Inc. RNAZ|Year-over-year net earnings per share change for the last twelve months Bionano Genomics Inc. (BNGO)|APDN: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months BLUE (bluebird bio Inc.)|IPA: Quarterly EPS earnings growth|OMGA (Omega Therapeutics Corp) - Year-over-year earnings per share growth for the last twelve months|OMIC (Singular Genomics Systems) - Quarterly EPS earnings growth|regulusrx.com (RGLS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Syros Pharmaceuticals, Inc. (SYRS)|TCON - Earnings per share growth in annualized terms for the last twelve months|Unity Bio - Year-over-year net earnings per share growth for the last 12 months